SCHEMBL4975609

SCHEMBL4975609

COC(=O)NCCO[C@@H](c1ccccc1)C1CCCN(C(=O)O)C1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.67
CYP3A4 P08684 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4975615 1.00 REN (0.67) RENCYP3A4
SCHEMBL12023114 0.92 REN (0.65) RENCYP3A4
SCHEMBL8242055 0.91 REN (0.72) RENCYP3A4
SCHEMBL4970990 0.90 REN (0.69) RENCYP3A4
SCHEMBL4970987 0.90 REN (0.69) RENCYP3A4
SCHEMBL970786 0.90 REN (0.70) RENCYP3A4
SCHEMBL4973694 0.90 REN (0.70) RENCYP3A4
SCHEMBL4973697 0.90 REN (0.70) RENCYP3A4
SCHEMBL970785 0.90 REN (0.70) RENCYP3A4
SCHEMBL2329120 0.88 REN (0.64) RENCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed